Glucose Blood Sugar Tracker is a mobile medical logging tool for individuals with diabetes to track glucose, medication, and health metrics.
Product velocity
Active
Daily rank 🇺🇸
#25
▼5Medical · grossing
Sentiment
4.6
28k reviews
Nemesis
mySugr - Diabetes Tracker Log
The App DNA
What makes this app unique?
Users hire the app to centralize health data for physician reporting, but the manual entry requirement creates friction that disrupts the daily logging habit.
For Individuals with diabetes or prediabetes requiring a centralized log for blood glucose, medication, and health metrics.
What does it look like?
Key features
Direct connection to Libre 2 continuous glucose monitors for live data ingestion
Calculates estimated HbA1c levels based on logged glucose entries
Writes glucose, weight, and blood pressure logs to the Apple Health app
How much does it cost?
The app currently operates as a free tool with no visible IAP or subscription gates, focusing on user acquisition.
Velocity
Active developmentShow more...
5 versions in history. Development pace: active.
Who built it?
App Sub 1
13+ apps tracked · Medical
User Sentiment
What do users think recently?
Fresh user feedback skews frustrated. Users appreciate estimated a1c tracking provides valuable health insights for long-term diabetic management.
How are ratings & reviews evolving?
What users say, by theme
- Estimated A1C tracking provides valuable health insights for long-term diabetic management
- Frequent application crashes during startup or data synchronization break the daily logging habit
49 of 49 recent reviews analyzed · high confidence · Frustrated overall
Read the full review analysisUnlock 1 more frustration theme and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Glucose | Blood Sugar Tracker
How's the Medical market?
The app maintains a 4.58 rating on the iOS platform, but the limited review count of 49 suggests a niche user base. The lack of Android presence and reliance on manual entry limits its ability to scale against category leaders.
Read the market outlookThe rivals identified
By mySugr GmbH
mySugr is the dominant market leader in the diabetes tracking niche with a massive, highly engaged user base and a mature, feature-rich ecosystem.
- Integrates directly with continuous glucose monitors to automate data logging and reduce manual entry friction
- Provides a gamified experience with challenges and feedback loops that significantly improve long-term user retention
- Offers a professional-grade PDF report generation feature that simplifies sharing health data with medical providers
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Glucose | Blood Sugar Tracker
Where is it heading?
Users report: The diabetes tracking market is consolidating around automated data ingestion, leaving manual trackers like this one exposed to high churn. Unless the app resolves its stability issues and clarifies its role as a manual tool, it will continue to lose users to hardware-integrated competitors.
- Frequent application crashes during startup break the daily logging habit, which compounds the rating drag already visible in recent reviews.
- Users report: Misleading marketing regarding automatic monitoring causes user frustration, leading to a surge in refund requests that threatens revenue stability.
The SWOT
- Clinical reporting exports increase switching costs for users
- A1C estimation provides long-term health value
- HealthKit sync reduces data entry friction
- Direct integration with wearable glucose monitors
- Expansion of food database for carbohydrate tracking
Next best moves
Audit startup sequence because frequent crashes break the daily logging habit → improve retention
+ 1 more prioritized moveThe counter-intuitive read
The app's reliance on manual entry is not just a feature gap…
Read the full takeFeature gaps
Automated CGM data ingestion (available in mySugr but absent here) +1
Since the last report: The app has transitioned to a free-only model while suffering from severe stability regressions and negative sentiment due to a disconnect between marketing and manual data entry requirements.
Bottom line
Users report: The app provides value through clinical reporting, but stability issues and misleading marketing drive high churn, so the PM must prioritize stability to retain the existing user base.
Unlock 3 critical frictions, 3 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated